Tricuspid regurgitation (TR) remains underdiagnosed due to the lack of effective screening tools. We developed a self-distilled and pre-trained transformer model for detecting TR (SPEED-TR) from electrocardiography. The model was trained using 466,149 electrocardiogram-echocardiogram…
Continue Reading
Cardiovascular diseases remain the leading cause of death in developed countries. This study introduces deep learning ensembles for arrhythmia detection and atrial fibrillation (AF) recurrence prediction from electrocardiogram scans, supported by explainable artificial intelligence…
Continue Reading
PreOpNet is a novel deep-learning algorithm using 12-lead digital electrocardiogram (ECG) for preoperative risk assessment of all-cause death and major adverse cardiac events (MACE) within 30 days. Its performance in European high-risk patients undergoing…
Continue Reading
Dr Arunashis Sau, academic clinical lecturer at Imperial College London’s National Heart and Lung Institute, and cardiology registrar at Imperial College Healthcare NHS Trust (Credit: Imperial College Healthcare NHS Trust)
Researchers have developed an…
Continue Reading
Findings from a previous study (ClinicalTrials.gov: NCT05118035) demonstrated that an AI-enabled electrocardiogram (AI-ECG), combining AI reports and physician alerts, effectively identified hospitalized patients at high risk of mortality and reduced all-cause mortality. This study…
Continue Reading
Artificial intelligence (AI)-ECG-derived age (AI-ECG age) and Heart Delta Age (HDA)—the difference between AI-ECG and chronological age—are emerging tools for assessing cardiovascular health. We systematically searched PubMed, Embase, Web of Science, and Scopus from…
Continue Reading
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection.
What You Should Know:
– AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its…
Continue Reading
What You Should Know:
– Researchers at Mount Sinai have enhanced an existing artificial intelligence (AI) algorithm to provide specific numeric probabilities identifying patients at risk for hypertrophic cardiomyopathy (HCM), a common inherited heart condition,…
Continue Reading
What You Should Know:
– HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a strategic collaboration with AccurKardia, an innovator in ECG-based diagnostics technology.
– The partnership…
Continue Reading
The COVID-19 pandemic accelerated the adoption of telehealth and remote monitoring in obstetric care. This study assessed pregnant patients’ perceptions before and after using a novel non-invasive fetal electrocardiogram (NI-FECG) device. The trial is…
Continue Reading
